Long-term effectiveness and safety of switching from originator to biosimilar infliximab in patients with Behçet's disease

Intern Emerg Med. 2019 Aug;14(5):719-722. doi: 10.1007/s11739-018-1970-3. Epub 2018 Oct 25.

¹ Rheumatology Unit, Department of Emergency and Organ Transplantation, Polyclinic Hospital, Piazza G. Cesare 11, 70124, Bari, Italy. glopalco@hotmail.it.
² Rheumatology Unit, Department of Emergency and Organ Transplantation, Polyclinic Hospital, Piazza G. Cesare 11, 70124, Bari, Italy.
³ Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases, Behçet's Disease Clinic and Rheumatology-Ophthalmology Collaborative Uveitis Center, University of Siena, Siena, Italy.
⁴ Department of Experimental and Clinical Medicine, University of Firenze, Florence, Italy.

^# Contributed equally.

No abstract available

Publication types